{"id":"https://openalex.org/W78516665","doi":null,"title":"[Cabergoline in the treatment of Parkinson's disease].","display_name":"[Cabergoline in the treatment of Parkinson's disease].","publication_year":2003,"publication_date":"2003-05-01","ids":{"openalex":"https://openalex.org/W78516665","mag":"78516665","pmid":"https://pubmed.ncbi.nlm.nih.gov/12721865"},"language":"es","primary_location":{"id":"pmid:12721865","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12721865","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurologia (Barcelona, Spain)","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027347263","display_name":"Pau P\u00e1stor","orcid":"https://orcid.org/0000-0002-7493-8777","observed_orcids":["https://orcid.org/0000-0002-7493-8777","https://orcid.org/0000-0002-2573-6378"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]},{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"P Pastor","raw_affiliation_strings":["Unidad de Parkinson y Movimientos Anormales Servicio de Neurolog\u00eda, Institut Clinic de Malaties del Sistema Nervi\u00f3s, IDIBAPS, Hospital Clinic, Facultad de Medicina de la Universidad de Barcelona, Barcelona, Spain. etolosa@clinic.ub.es"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unidad de Parkinson y Movimientos Anormales Servicio de Neurolog\u00eda, Institut Clinic de Malaties del Sistema Nervi\u00f3s, IDIBAPS, Hospital Clinic, Facultad de Medicina de la Universidad de Barcelona, Barcelona, Spain. etolosa@clinic.ub.es","institution_ids":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I71999127"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078689202","display_name":"EDUARDO S. TOLOSA","orcid":"https://orcid.org/0000-0002-3781-0854","observed_orcids":["https://orcid.org/0000-0002-3781-0854"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Tolosa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0497,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.74278371,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"18","issue":"4","first_page":"202","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13991","display_name":"Nuclear Receptors and Signaling","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cabergoline","display_name":"cabergoline","score":1.0},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dopamine-d2-receptor-agonist","display_name":"dopamine D2 receptor agonist","score":0.9079999923706055},{"id":"https://openalex.org/keywords/dopamine-agonists","display_name":"dopamine agonists","score":0.8080000281333923},{"id":"https://openalex.org/keywords/levodopa-induced-motor-complications","display_name":"levodopa-induced motor complications","score":0.8650000095367432},{"id":"https://openalex.org/keywords/dystonia","display_name":"dystonia","score":0.9229999780654907},{"id":"https://openalex.org/keywords/sleep-disturbance","display_name":"sleep disorders","score":0.8069999814033508},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.6119999885559082},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.5070000290870667},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.6990000009536743}],"concepts":[{"id":"https://openalex.org/C2779832395","wikidata":"https://www.wikidata.org/wiki/Q423308","display_name":"Cabergoline","level":4,"score":0.9957469701766968},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.7844166159629822},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.6996952295303345},{"id":"https://openalex.org/C2780304432","wikidata":"https://www.wikidata.org/wiki/Q300989","display_name":"Levodopa","level":4,"score":0.6696161031723022},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6528686881065369},{"id":"https://openalex.org/C2778258207","wikidata":"https://www.wikidata.org/wiki/Q600203","display_name":"Dopamine agonist","level":4,"score":0.5987093448638916},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.4300290644168854},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3628435432910919},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3530708849430084},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.32935044169425964},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.09335494041442871},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077465","descriptor_name":"Cabergoline","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004873","descriptor_name":"Ergolines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004873","descriptor_name":"Ergolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004873","descriptor_name":"Ergolines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:12721865","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12721865","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurologia (Barcelona, Spain)","raw_type":"Journal Article"},{"id":"mag:78516665","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12721865","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2152581055","https://openalex.org/W1973962177","https://openalex.org/W111468672","https://openalex.org/W2168445983","https://openalex.org/W2049494877","https://openalex.org/W1965340866","https://openalex.org/W2057667341","https://openalex.org/W1979939317","https://openalex.org/W2090759573","https://openalex.org/W1991532709"],"abstract_inverted_index":{"Cabergoline":[0,19,42,80,99,158,196],"(1-[(6-allelylergolin-8":[1],"beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethyl-urea)":[2],"is":[3,20,43,88,127,136,197],"a":[4,39,198],"new":[5],"agonist":[6],"of":[7,16,69,96,106,114,120,149,166,219],"the":[8,14,56,67,93,104,112,118,121,150,164,209],"D2":[9],"dopaminergic":[10,78,225],"receptors":[11],"used":[12,83],"in":[13,50,66,84,138,163,186,208,221,230],"treatment":[15,95,131,165],"Parkinson's":[17,70,97,172,191],"disease.":[18,98,134],"characterized":[21],"by":[22,76],"unique":[23],"pharmacologic":[24],"properties,":[25],"such":[26,174],"as":[27,46,175],"its":[28],"long":[29],"plasma":[30],"half-life":[31],"(about":[32],"68":[33],"hours),":[34],"which":[35],"allows":[36],"for":[37,92,117,132,156],"once":[38],"day":[40],"administration.":[41],"well":[44,199],"tolerated,":[45],"has":[47],"been":[48],"shown":[49],"several":[51],"clinical":[52,232],"trials.":[53],"Based":[54],"on":[55,183],"information":[57],"available,":[58],"we":[59],"suggest":[60,124],"that":[61,125],"cabergoline":[62,126,220],"produces":[63],"an":[64,89,128],"improvement":[65,137],"symptoms":[68,140],"disease":[71,173,192],"similar":[72],"to":[73,223],"those":[74],"produced":[75],"other":[77,224],"agonists.":[79],"monotherapy,":[81],"when":[82],"previously":[85],"untreated":[86],"patients,":[87],"appropriate":[90],"option":[91],"symptomatic":[94],"improves":[100],"motor":[101,108,139],"symptoms,":[102],"delays":[103],"presentation":[105],"levodopa-induced":[107],"complications,":[109],"and":[110,147,153,178,211,215],"diminishes":[111],"amount":[113],"levodopa":[115],"required":[116],"control":[119],"symptoms.":[122],"We":[123],"adequate":[129],"adjuvant":[130],"Parkinson'":[133],"There":[135],"(without":[141],"substantially":[142],"increased":[143],"dyskinesias),":[144],"reduced":[145],"severity":[146],"duration":[148],"wearing-off":[151],"period,":[152],"diminished":[154],"need":[155],"levodopa.":[157],"can":[159],"also":[160],"be":[161,228],"useful":[162],"sleep":[167],"disturbances":[168,188],"associated":[169,189],"with":[170,190],"advanced":[171],"nocturnal":[176,187],"akinesia":[177],"dystonia.":[179],"However,":[180],"additional":[181],"studies":[182],"cabergoline's":[184],"effects":[185,204],"are":[193,205],"still":[194],"required.":[195],"tolerated":[200],"drug.":[201],"Its":[202],"side":[203],"seen":[206],"mainly":[207],"digestive":[210],"nervous":[212],"system":[213],"(central":[214],"peripheral).":[216],"The":[217],"efficacy":[218],"comparison":[222],"agonists":[226],"should":[227],"tested":[229],"future":[231],"studies.":[233]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}